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Abstract
Background: Multiple studies have linked fungal exposure to asthma, but the link to severe
asthma is controversial. We studied the relationship between asthma severity and immediate type
hypersensitivity to mold (fungal) and non-mold allergens in 181 asthmatic subjects.
Methods: We recruited asthma patients aged 16 to 60 years at a University hospital and a nearby
General Practice. Patients were categorized according to the lifetime number of hospital
admissions for asthma (82 never admitted, 53 one admission, 46 multiple admissions). All subjects
had allergy skin prick tests performed for 5 mold allergens (Aspergillus, Alternaria, Cladosporium,
Penicillium and Candida) and 4 other common inhalant allergens (D. pteronyssinus, Grass Pollen, Cat
and Dog).
Results: Skin reactivity to all allergens was commonest in the group with multiple admissions. This
trend was strongest for mold allergens and dog allergen and weakest for D. pteronyssinus. 76% of
patients with multiple admissions had at least one positive mold skin test compared with 16%-19%
of other asthma patients; (Chi squared p < 0.0001). Multiple mold reactions were also much
commoner in the group with multiple admissions (50% V 5% and 6%; p < 0.0001). The number of
asthma admissions was related to the number and size of positive mold skin allergy tests (Spearman
Correlation Coefficient r = 0.60, p < 0.0001) and less strongly correlated to the number and size
of non-mold allergy tests (r = 0.34, p = 0.0005). Hospital admissions for asthma patients aged 16–
40 were commonest during the mold spore season (July to October) whereas admissions of
patients aged above 40 peaked in November-February (Chi Squared, p < 0.02).
Conclusion:  These findings support previous suggestions that mold sensitization may be
associated with severe asthma attacks requiring hospital admission.
Background
Most asthma patients have mild symptoms which are well
controlled with anti-inflammatory and bronchodilator
therapy but a minority of asthma patients have severe air-
way inflammation and airflow obstruction requiring mul-
tiple hospital admissions. The reasons for these
differences in asthma severity are complex and not fully
understood [1]. At least two thirds of asthmatic patients
are atopic with skin reactivity to common allergens [2-4].
It has also been reported that individuals with severe
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("brittle") asthma may have a greater degree of atopy than
other asthmatic patients [5]. Skin reactivity to fungal aller-
gens such as Alternaria species has been reported to be
especially common in patients with life-threatening
asthma [6]. Asthma deaths, hospital admissions, respira-
tory symptoms, and Peak Expiratory Flow rates can be
adversely affected by high fungal spore concentrations in
outdoor air [7-11]. Mold sensitivity has been associated
with increased asthma severity and intensive care admis-
sions in adults and with increased bronchial reactivity in
children [12-17].
Indoor mold exposure might also contribute to asthma
severity. Many patients believe that their asthma is aggra-
vated by damp housing, especially if there is visible mold
growth [18]. It has been reported that asthma patients are
more likely than control patients to live in a damp dwell-
ing and their asthma severity was correlated to the degree
of dampness and mold growth in their home (measured
by a building surveyor) [19]. It is also known that asthma
deaths in young adults in England and Wales are com-
monest in the months of July, August and September
which coincides with peak levels of mold spores in the
outdoor air in the UK [20-22].
These studies prompted us to undertake a study of asth-
matic patients in Salford in Greater Manchester (North-
West England) to assess whether atopy in general and
mold sensitization in particular was associated with
increased asthma severity. There are few agreed defini-
tions of severe asthma so we used hospital admissions
and treatment category (according to British Thoracic
Society Asthma Guidelines) as surrogate markers for
asthma severity [23].
Methods
This study was undertaken in Hope Hospital, a 900 bed-
ded University Hospital in Salford, Greater Manchester,
UK. The study was designed to record the atopic status for
mold and non-mold allergens of asthma patients at every
level of severity from very mild to very severe (defined as
multiple hospital admissions despite intensive asthma
medication). We studied patients with severe asthma dur-
ing hospital admissions or at subsequent visits to the hos-
pital chest clinic. Patients were recruited opportunistically
during hospital admissions or during routine consulta-
tions with the Respiratory Nurse Specialist (RNS) in the
hospital Chest Clinic. Recruitment was evenly spread over
30 months from January 1996 to June 1998. During this
period, the Respiratory Nurse service was under develop-
ment with only one part-time RNS available to serve a
large population of hospital in-patients and ambulatory
care patients at chest clinics. Ward-based doctors and
nurses referred patients with acute asthma to the RNS on
an opportunistic basis based on availability of the part-
time RNS and whether the ward teams were aware of the
developing RNS service. About 20% of all adult asthma
patients admitted during the study period were referred to
the RNS and most of these were recruited in the study
(provided the RNS had time available to do so). Although
recruitment was not systematic (based mainly on availa-
bility of RNS service), we were not aware of any potential
bias which might have affected the recruitment process
and we believe that the recruited patients were typical of
adult patients with acute asthma admitted to our hospital.
We recruited ambulatory patients (some of whom had
previous hospital admissions) at the same hospital chest
clinic and in a single Primary Care practice where 25
patients were recruited during routine consultations with
the practice nurse. This recruitment was also opportunis-
tic, based mainly on the availability of time to complete
the study protocol during busy clinics. We believe that
these patients were typical of patients seen at hospital
chest clinics and General Practice asthma clinics in this
area. Patients were grouped according to their lifetime his-
tory of hospital admissions for asthma (multiple admis-
sions, single admission, or no admissions). Patients with
no hospital admissions were further categorized accord-
ing to the treatment steps described in the British Thoracic
Society guidelines for asthma management; Step 1 requir-
ing only occasional bronchodilator treatment, Step 2
requiring low-doses (<800 mcg per day) of inhaled ster-
oid, Step 3 requiring high doses of inhaled steroids or
long acting beta agonists, Step 4 requiring additional ther-
apy such as domiciliary nebulized therapy [23]. We
attempted to recruit approximately equal numbers of
patients at BTS steps 1, 2 and 3–4 to allow analysis of
mold sensitization according to severity in non-admitted
patients as well as in admitted patients.
All patients were Caucasians who were lifelong residents
of the United Kingdom. Inclusion criteria were a diagnosis
of asthma by the patient's doctor, age 16 to 60 and ability
to give informed consent. All subjects gave written
informed consent prior to partaking in the study which
was approved by the Salford Research Ethics Committee.
Exclusion criteria included a diagnosis of COPD, non-
European ethnic group (98% of Salford residents are Cau-
casian) and consumption of any antihistamine in the pre-
vious 48 hours. All subjects completed a questionnaire
concerning respiratory symptoms, smoking status and
allergies.
All tests were conducted by one author (LCH) or by one
other respiratory nurse specialist using a standardized
technique in an open manner. A small drop of allergen
was placed on the volar surface of the forearm. Allergens
were purchased from Allergopharma (Reinbek, West Ger-
many), a single batch of each allergen was used through-
out the study. We used skin test lancets with a 1 mm tipBMC Pulmonary Medicine 2005, 5:4 http://www.biomedcentral.com/1471-2466/5/4
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(Bayer Prick Lancetter supplied by Miles Pharmaceutical
Division, Spokane, Washington, USA). The lancet was
introduced vertically into the skin through the allergen
solution. Allergens studied were: negative control, hista-
mine 0.1%, Dermatophagoides pteronyssinus, cat, dog,
mixed grass pollen, Aspergillus fumigatus, Alternaria alter-
nata, Cladosporium herbarum, Penicillium notatum and Can-
dida albicans.
Weal diameter (if any) was recorded at 15 minutes. If a
weal was asymmetrical, the mean of two perpendicular
measurements was calculated. Weals less than 3 mm
greater than the negative control reaction were regarded as
negative in accordance with guidance issued by the Euro-
pean Academy of Allergology [24]. We devised an arbi-
trary numerical "sensitization score" for mold
sensitization and non-mold sensitization to compare the
number and size of positive allergy tests between groups
of patients. This "sensitization score" was the sum of all
positive weal diameters for each individual patient after
subtraction of the negative control. For example, a patient
with a 1 mm reaction to negative control, a 6 mm reaction
to Aspergillus and a 5 mm reaction to Cladosporium would
have a "mold sensitization score" of (6-1)+(5-1) = 9 mm.
As a subsidiary study (not part of the initial trial protocol),
we also studied the seasonality of asthma admissions in
Salford by reviewing the electronic records of 520 asthma
admissions under the care of two pulmonary physicians
who kept a computerized database at this hospital
between 1995 and June 2000 (approximately 30% of all
adult asthma admissions to the hospital). This covered a
wide time-span before, during and after the period of the
mold sensitization study; some of the allergy study
patients were admitted and recruited during this time but
they represented only a small (and random) proportion
of the admissions studied for seasonality. Asthma admis-
sions were analyzed by month of admission and divided
into 3 four-month "seasons"; March to June (Spring and
early summer season with maximum airborne levels of
shrub, tree and grass pollens; July to October (late sum-
mer and fall season with maximum airborne levels of
mold spores); November to February (winter peak of gen-
eral respiratory infections involving COPD and older
asthma patients); [20-22]. Patients were analyzed in two
age groups as it is known that asthma admissions and
asthma deaths in Britain are commonest in July to Sep-
tember for patients aged under 35 but older patients are
more likely to suffer asthma death in winter [20,21]. We
used two age bands (16–40 and >40) because our patients
aged 35–40 had a seasonal profile for asthma admissions
which was identical to the 16–35 group and different to
the group aged above 40.
Statistical analysis was performed using Prism II software
(GraphPad Prism, San Diego, California, USA). Chi
squared test was used to compare the number of positive
allergy skin tests between groups of asthma patients.
Spearman Correlation Coefficient was used to compare
each patients lifetime number of hospital admissions with
their "Mold sensitization score" (as described above).
Mann Whitney tests were used to compare mean sensiti-
zation scores between groups of patients.
Results
One hundred eighty-one asthmatic patients were
recruited. Their characteristics are given in table 1. No sub-
ject was on antihistamine medication and none had a
negative reaction to histamine. No subjects had dermatog-
raphism (>3 mm reaction to negative control skin test).
No eligible patient declined to partake in the study. There
was a predominance of female subjects in all groups.
Patients with hospital admissions were more likely to
report current smoking than patients with no admissions
(p = 0.03). The habit was commoner amongst patients
with one admission than those with multiple admissions
but this difference was not significant (p = 0.18). Patients
with multiple admissions were more likely to have devel-
oped their asthma in childhood and they had a stronger
family history of asthma.
Positive skin tests to all allergens were commoner in the
group with severe asthma (multiple hospital admissions)
than patients with milder asthma. (Table 2 and Figure 1).
Atopic sensitization was common in all groups, especially
the severe asthma group This tendency was most marked
for dog sensitization (Table 2). Dog ownership was 31%
amongst patients with mild asthma (no admissions) and
30% amongst those with multiple admissions (who were
more dog-allergic).
Mold sensitization was uncommon in mild asthma but
very common in asthma patients with multiple admis-
sions (Figure 1 and Table 2). There was a striking differ-
ence in the prevalence of mold sensitization amongst the
three asthma groups. Three quarters of patients with mul-
tiple hospital admissions were sensitized to molds and
half of them reacted to multiple mold allergens. The
patients with a single hospital admission were more sim-
ilar to those with no admissions than to the multiple
admission group. This trend was seen for all five mold
allergens studied (table 2). The frequency of sensitization
to any individual mold ranged from 26% (Alternaria) to
41% (Cladosporium) in the severe asthma group compared
with 0–10% in the milder asthma groups.
Aspergillus and Candida precipitins and specific IgE were
not measured in this study. None of these patients had
any clinical features suggestive of allergicBMC Pulmonary Medicine 2005, 5:4 http://www.biomedcentral.com/1471-2466/5/4
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bronchopulmonary aspergillosis (ABPA) such as pulmo-
nary infiltrates, bronchiectasis or marked eosinophilia.
The number of admissions correlated with the number
and size of positive skin tests using the scoring system
described previously. For mold sensitization, the Spear-
man Correlation Coefficient was 0.60 (two-tailed p <
0.0001) and for non-mold allergens was 0.34 (two-tailed
p = 0.0005). The cumulative "mold sensitization score"
Table 1: Patient characteristics.
Asthma No 
Hospital 
Admissions
Asthma One 
Hospital Admission
Asthma >1 Hospital 
Admission
Number 82 53 46
32 BTS step 1 (Ref 23)
25 BTS step 2
25 BTS steps 3–4
Percent male 35% 25% 46%
Mean Age (Range) 37 36 36
16–59 17–58 16–60
%Smokers 15% 34% 22%
%Ex-Smokers 29% 23% 17%
%Non-Smokers 56% 43% 61%
Asthma onset before age 16 (Percent) 44% 23% 70%
Family history of Asthma in parents, siblings or children (%) 56% 55% 76%
Table 2: Prevalence of mold and non-mold sensitization in asthma patients. "Sensitization score" refers to number and size of positive skin 
tests as defined in methods section.
Asthma No 
admissions
Asthma One 
Admission
Asthma >1 
admissions
Chi squared p value
Mold allergens
Aspergillus 7% 6% 37% <0.0001
Alternaria 5% 6% 26% <0.0001
Cladosporium 1% 0% 41% <0.0001
Penicillium 2% 4% 30% <0.0001
Candida 10% 9% 33% 0.001
Any mold sensitization 16% 19% 76% <0.0001
>1 mold sensitisation 5% 6% 50% <0.0001
Mean mold sensitization score (95% CI) 0.9 mm 0.4–1.4 0.9 mm 0.3–1.5 6.7 mm 4.8–8.5 Mann Whitney See below
Other allergens
D pteronyssinus 56% 47% 67% 0.13
Grass pollen 46% 38% 63% 0.025
Cat 37% 36% 59% 0.029
Dog 18% 19% 48% 0.005
Any non-mold Sensitisation 70% 47% 74% 0.008
>1 non-mold sensitisation 43% 38% 70% 0.002
Mean non-mold sensitization score 
(95% CI)
8.6 mm 6.6–10.6 7.0 mm 4.7–9.3 14.5 mm 11.1–17.9 Mann Whitney See below
Mann Whitney Analysis of "Sensitization Scores" between different categories of asthmatic patients.
Mold sensitization score: 
No admission V single admission P = 0.87
No admission V multiple admissions P = < 0.0001
Single admission V multiple admissions P = < 0.0001
Non- Mold sensitization score:
No admission V single admission P = 0.29
No admission V multiple admissions P = < 0.009
Single admission V multiple admissions P = 0.002BMC Pulmonary Medicine 2005, 5:4 http://www.biomedcentral.com/1471-2466/5/4
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and the "non-mold sensitization score" for each group of
patients is shown in table 2. Only two of the 99 patients
with asthma admissions had ever required admission to
an Intensive Care Unit. Both were sensitized to a single
mold (one Aspergillus, one Penicillium).
Of the patients not admitted to hospital, 32 had very mild
asthma (BTS Step 1), 25 had mild-moderate asthma (BTS
Step 2) and 25 had moderate to severe asthma (BTS Steps
3–4). There was no significant difference in mold or non-
mold sensitization between these groups of non-admitted
patients with different grades of asthma severity.
Our review of asthma admissions to this hospital between
1995 and 2000 identified 520 patients admitted under
the care of the two chest physicians who kept a computer-
ized database (approximately 30% of all asthma admis-
sions to the hospital). There were 173 asthma admissions
in the 16–40 age group, these admissions peaked in late
summer and fall (figure 2). Of these admissions 24.3%
occurred between March and June, 43.4% between July
and October and 32.4% between November and Febru-
ary. By contrast, 347 asthma patients aged over 40 had a
winter peak of admissions (30.3% March-June, 30.5%
July-Oct, 39.2% Nov-Feb) These patterns of admissions
Mean mold sensitization scores and mean non-mold sensitization scores for asthma patients and controls (mean and 95% CI) Figure 1
Mean mold sensitization scores and mean non-mold sensitization scores for asthma patients and controls (mean and 95% CI) 
Clear bar: 82 asthma patients with no hospital admissions. Grey bar : 53 patients with one hospital admission Striped bar: 46 
patients with more than one hospital admission.
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were significantly different (Chi squared p < 0.02). The
summer-fall peak in the 16–40 age group amounted to 33
additional admissions above the spring baseline. This
represented 6.4% of all asthma admissions or 19.1% of
admissions in the 16–40 age group.
Discussion
Although the present study was larger than most previous
studies of mold sensitization in severe asthma, it must be
regarded as a "pilot study" due to the non-systematic
recruitment of asthma patients and the cross-sectional
Asthma admissions aggregated by "season", comparing 16–40 age group (black bars) with age >40 (white bars) Figure 2
Asthma admissions aggregated by "season", comparing 16–40 age group (black bars) with age >40 (white bars).
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nature of the study. Our data indicate that mold (and dog)
sensitization is common in patients with severe asthma
requiring multiple hospital admissions in Manchester.
The results are consistent with previous evidence that
atopy (especially to mold allergens) is related to asthma
severity or bronchial hyper-reactivity [4-6,12-17]. A recent
cross-sectional study of 1132 adults with asthma found
that sensitization to Alternaria or Cladosporium is a power-
ful risk factor for severe asthma[16] in several European
countries and also in Australia, New Zealand and in Port-
land, Oregon. The link between dog sensitization and
asthma severity is in agreement with previous studies
[5,14]. We had also expected to find an excess of house
dust mite (D. pteronyssinus) sensitization in our patients
with more severe asthma [15,25]. However, reactivity to
this allergen was common in all asthma groups and only
slightly commoner in patients with multiple admissions.
There has been some debate about the best cut-off point
for weal size to define a positive skin-prick test. We
accepted the European Academy of Allergology figure of 3
mm greater than the negative control [24]. However, re-
analysis of our data using a 2 mm or 4 mm difference
from the negative control would make no difference to
the results. Furthermore, the number and size of positive
skin tests to mold allergens was greatest in patients with a
high number of admissions suggesting that the relation-
ship is a genuine one. It was also notable that, although
sensitization to non-mold allergens was common in the
informal control population and in patients with mild
asthma, mold sensitization was uncommon in these
groups. This indicates that the positive skin tests to mold
allergens are unlikely to be due to irritant reactions of a
non-allergic nature. As skin test reagents from different
manufactures are not standardized, different results might
be obtained with different manufacturers' reagents. Until
such antigens are standardized, this remains unsatisfac-
tory. However, the consistency between the present study
and the recent European Community respiratory health
survey (using different antigens) supports the validity of
the association between mold sensitization and severe
asthma.
A key question is whether severe asthma is actually caused
by sensitivity to molds or is simply associated with it. In
any case, mold sensitivity will certainly not be the only
cause of severe attacks of asthma; upper respiratory tract
virus infections and some drugs being two of other well
documented causes. The greater degree of mold sensitiza-
tion in the severe asthma group could simply reflect an
extreme example of the generalized increase in atopy
amongst this group. However, we believe that mold
allergy may be responsible for severe asthma attacks for
several reasons.
First, the temporal relationship between high environ-
mental spore counts and asthmatic attacks is strong. Air-
borne spore levels may be up to 1000 times higher than
pollen levels [26]. The data of Targonski and colleagues
provide strong evidence that asthma deaths in Chicago are
more likely to occur on days when local mold spore
counts are high [7]. High mold spore counts have been
associated with asthma admissions in New Orleans
(adults) and in Derby, UK (adults and children) [10,11].
Asthma symptoms are increased in California and Penn-
sylvania on days when mold spore counts are high [8,9].
The young patients of O'Hollaren and colleagues who
were  Alternaria-sensitive had their near-fatal asthma
episodes in summer and early fall when mold spore levels
would be expected to be high [6].
Second, the seasonal (summer -fall) peak of asthma
admissions occurs when ambient air counts of molds are
high. We have documented a late summer-fall peak of
asthma admissions involving young adults in Manchester
which coincides with the summer-fall peak of asthma
deaths in UK patients aged under 35 years [20,21]. These
asthma admissions also coincide with the peak months
for outdoor levels of fungal spores [22,27]. Although
there is no aero-biology service in Manchester, data for
surrounding towns have shown a consistent summer-fall
peak in mold spore counts. In Cardiff, for example, a city
150 miles south-west of Manchester with a similar cli-
mate, the highest spore counts were measured in late sum-
mer and fall [22]. The Cardiff authors reported maximal
levels of Cladosporium in July, Alternaria and hyaline basid-
iospores in August, uredospores in September and col-
oured basidiospores in October. The data from Derby (52
miles south-east of Manchester) are similar[11]. In addi-
tion, similar findings have been reported from Copenha-
gen (600 miles north-east of Manchester) where 87% of
the microfungal flora in outdoor air is accounted for by
Cladosporium, Alternaria, Penicillium and Aspergillus with
maximal levels between June and October [27]. A pan-
European study with centres in Oregon, USA, Australia
and New Zealand involving questionnaires and skin prick
tests in 17,000 patients identified 1132 patients with
asthma the severity of which could be determined [16].
Sensitisation to A. alternata and C. herbarium was com-
mon and associated with asthma severity – OR of 2.03 for
the former, of 3.2 for the latter fungus and 2.34 for both.
No such association was found for pollens or cats,
although sensitization to house dust mite was slightly
more frequent in those with severe asthma (OR 1.61)
[16]. The present study extends these findings to a wider
range of fungal allergens and a greater degree of asthma
severity.
Third, there is evidence that indoor mold exposure may
contribute to asthma severity. Many patients reportBMC Pulmonary Medicine 2005, 5:4 http://www.biomedcentral.com/1471-2466/5/4
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respiratory symptoms in damp and moldy houses and a
review of nine population-based studies found that seven
reported one or more positive associations between fun-
gal levels and health outcomes [28]. The study of William-
son and colleagues in Scotland reported that asthmatic
patients were more than twice as likely than control
patients to live in a house that was considered damp or
moldy by a building surveyor [19]. Furthermore, in that
study, there was a positive association between a patient's
asthma severity and the degree of dampness which the
surveyor measured in the patient's home (r = 0.3, p =
0.006) and independently with an index of visible mold
growth in their dwelling (r = 0.23, p = 0.035). In a study
of German children, it was found that bronchial hyper-
reactivity was associated with damp housing [29] that was
only partly explained by exposure to house dust mite anti-
gen, suggesting that other factors such as mold growth
may also be important. Taskinen et al found that the
prevalence of asthma was similar (4.8%) amongst chil-
dren attending a school with moisture and mold prob-
lems compared with a control school but asthma
symptoms such as wheeze and cough were commoner in
the damp moldy school as were emergency visits to hospi-
tal (OR 2.0, p < 0.01) [30].
Fourth, we know that Aspergillus in particular is a major
respiratory allergen causing the vast majority of cases of
allergic bronchopulmonary mycosis [31-33]. It is likely
that these cases represent the extreme of a spectrum of
mold allergy, the slightly less severe manifestation of
which is severe asthma as described in this study and with-
out all the serological and radiological markers character-
isitic of ABPA. The reactivity of asthmatic patients to
multiple mold allergens could be due to genuine sensiti-
zation to a variety of molds or it could be due to cross-
reactivity between mold allergens. The paper of Hem-
mann and colleagues suggests that Aspergillus and Candida
allergens may share IgE-binding epitopes [34]. However,
it is believed that multiple mold sensitization skin test
reactions are usually due to sensitivity to multiple anti-
gens rather than cross reactivity [25]. Few fungi of the >1
million species of fungi thought to exist worldwide have
been subjected to the antigenic scrutiny that Aspergillus
and a few other common airborne fungi have and it is
likely that sensitization to other fungi will be discovered
in the future.
It is not known why mold allergens should produce more
severe airway disease than other common allergens such
as house dust mites, cat dander, or grass pollen. Fungi are
very common in the environment and Candida is present
in the gut of most, if not all, humans. The difference may
relate to the nature or intensity of exposure to mold aller-
gens or to their ability to become airborne and to gain
entry to human airways due to their small size. Also many
potent allergenic proteins have been described in Aspergil-
lus and some in other fungi [35]. There is the probability
that some fungal antigens, such as Asp f6 being a manga-
nese dependant superoxide dismutase which is closely
related to the human enzyme, might set up a self perpetu-
ating allergic response, which is aggravated every time
Aspergillus is inhaled, which is almost hourly. Some fungal
antigens are proteases (Asp f5, Asp f10, Asp f13, Asp f15,
Asp f18) and as DP1 is also a protease – a similar patho-
genic role can be postulated [35,36].
It therefore seems likely that there is a causal relationship
between mold allergy and asthma severity for some
younger asthma patients. Our seasonal admissions data
suggest that up to 6% of adult asthma admissions in Man-
chester and 19% of asthma admissions in the 16–40 age
group may be attributable to mold allergy. These unlucky
individuals seem to have more severe asthma than
patients with sensitization to other common allergens
and an increased risk of fatal or near-fatal asthma or hos-
pital admissions during the mold spore season, especially
on days when the local mold spore count is high. The risk
may be further increased if the patient lives in a damp,
moldy house or attends a damp moldy school
[19,29,30,37]. It is not yet known which mold species are
most important in causing such reactions or whether
indoor or outdoor mold exposure is more important
{outdoor levels are usually higher}[38]. It is very difficult
to make accurate measurements of indoor mold exposure
and most studies have used surrogate markers such as
dampness or visible mold growth. This phenomenon
needs to be studied further in a variety of geographic loca-
tions with different climates. It is not yet known if envi-
ronmental modification or the use of airway protection
would be of any value in the management of mold-aller-
gic asthma patients.
One of the fungi which we investigated and for which
antigenic extracts are available, Candida albicans, is a yeast,
does not become airborne but does produce hyphae in tis-
sue. Thus it is possible that human asthma due to fungal
allergens may have three sources of allergen exposure –
outdoor mold spores, indoor mold spores and endog-
enous fungal growth on body surfaces including the skin
and gut [33].
Fungal sensitization is relatively uncommon in our British
asthma patients and in Finnish schoolchildren [30] com-
pared with Arizona [12] and Australia where up to 31% of
asthmatic children and up to 23% of non-asthmatic con-
trols react to at least one fungal allergen [15,17,37]. The
prevalence of Alternaria sensitization in Italian patients
with respiratory symptoms ranges from 2% in Northern
Italy to 29% in Southern Italy [39]. Some of these differ-
ences are probably due to difficulties in theBMC Pulmonary Medicine 2005, 5:4 http://www.biomedcentral.com/1471-2466/5/4
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standardization of mold allergen extracts or skin testing
techniques [26]. Also fungal sensitization is commoner in
children and declines with age. However, it is likely that
the significance of a positive skin test to fungal allergens
varies in different climatic zones. Our data and those of
O'Hollaren, Sureik and Black [6,16,17] suggests that fun-
gal skin sensitization tests may identify adults who are at
risk of especially severe asthma. The difference in the prev-
alence of mold sensitization between patients with multi-
ple asthma admissions and the other groups in our study
was so striking that it is extremely unlikely to have
occurred by chance. Mold allergy tests may be useful to
screen for children and adults who are at greatly increased
risk of developing severe or fatal asthma. A large prospec-
tive study will be required to confirm these preliminary
findings.
Conclusion
The findings of this study support previous suggestions
that mold sensitization may be associated with severe
asthma attacks requiring hospital admission.
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